Back to Researchers
Profile photo Patricia Bruijning-Verhagen

Patricia Bruijning-Verhagen

Full Professor

Strategic program(s):

Biography

Background

 

Dr. Bruijning is a pediatrician and epidemiologist. She studies common childhood infections, vaccination and emerging infectious diseases including COVID-19. Her research has a strong focus on Public Health and policy. She has been PI of several large scale vaccine studies, including rotavirus, influenza, pneumococcal and COVID-19 vaccines evaluating vaccine effectiveness, immunogenicity, timing and implementation. Her scientific work has been instrumental in vaccine Advisory Statements by the Dutch Health Counsel, where served as an external advisor, in clinical guidelines and in vaccine policy decisions. She holds a cross-appointment at the RIVM Center for Infectious Disease Control, where she contributed to numerous vaccine guidelines. She has a strong interest in understanding dynamics of (emerging) infectious diseases and the role of children in transmission, for which she obtained a VENI career grant in 2015 and a VIDI career grant in 2020. She is has lead three large scale population transmission studies on COVID-19 funded by ZonMw and the European Commission.  With her VIDI career grant she is studying interactions between key respiratory viruses in children, including SARS-CoV2, and their implications for vaccination policies. She has published >80 articles including peer-reviewed papers, professional guidelines, scientific reports and publications for the lay public. She has a strong international network as evidenced by her involvement in several international emerging infections research consortia funded by the Innovative Medicine Initiative and the European Commission (ZIKAction, OneHealth-PACT, RECOVER, COVID-RED, Neo-Deco, VACCELERATE). She is a member of the COVID-19 taskforce of the Dutch Pediatric Society and of the COVID-19 scientific committee of the Federation of Medical Specialists. She served as scientific advisor on COVID-19 for the Minister of Health and of Education. She coordinates and teaches MSc courses in infectious diseases epidemiology and vaccines (Utrecht University, McGill University) and vaccinology masterclasses for healthcare professionals. She communicates actively on Twitter (@P_Bruijning) about infectious diseases and vaccines.

 

 

Research groups

Epidemiology and clinical trials in infectious diseases

Research aim

To improve prevention, diagnosis and treatment of infectious diseases and to establish an international research infrastructure for a rapid scientific response in the face of a new infectious disease threat.

Go to group

Recent publications

Non-specific effects of the inactivated influenza vaccine. A test-negative study Anne Jasmijn Sellies, Mirjam J. Knol, Hester E. de Melker, Patricia C.J.L. Bruijning-Verhagen, Annemarijn R. de Boer
Vaccine, 2024, vol. 42, p.3455-3460
Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study Michiel van Boven, Christiaan H van Dorp, Ilse Westerhof, Vincent Jaddoe, Valerie Heuvelman, Liesbeth Duijts, Elandri Fourie, Judith Sluiter-Post, Marlies A van Houten, Paul Badoux, Sjoerd Euser, Bjorn Herpers, Dirk Eggink, Marieke de Hoog, Trisja Boom, Joanne Wildenbeest, Louis Bont, Ganna Rozhnova, Marc J Bonten, Mirjam E Kretzschmar, Patricia Bruijning-Verhagen
PLoS Computational Biology, 2024, vol. 20
Education pathways and key tasks for research nurses in Europe, results from a VACCELERATE online survey Jon Salmanton-García, Fiona A. Stewart, Pauline Wipfler, Sanne H.I. Hofstraat, Patricia Bruijning-Verhagen, Oliver A. Cornely
Nurse Education in Practice, 2024, vol. 77, p.1-7
Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study Michiel van Boven, Christiaan H van Dorp, Ilse Westerhof, Vincent Jaddoe, Valerie Heuvelman, Liesbeth Duijts, Elandri Fourie, Judith Sluiter-Post, Marlies A van Houten, Paul Badoux, Sjoerd Euser, Bjorn Herpers, Dirk Eggink, Marieke de Hoog, Trisja Boom, Joanne Wildenbeest, Louis Bont, Ganna Rozhnova, Marc J Bonten, Mirjam E Kretzschmar, Patricia Bruijning-Verhagen
2023
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation Angela Mc Rose, Nathalie Nicolay, Virginia Sandonis Martín, Clara Mazagatos, Goranka Petrović, F Annabel Niessen, Ausenda Machado, Odile Launay, Sarah Denayer, Lucie Seyler, Joaquin Baruch, Cristina Burgui, Isabela I Loghin, Lisa Domegan, Roberta Vaikutytė, Petr Husa, George Panagiotakopoulos, Nassera Aouali, Ralf Dürrwald, Jennifer Howard, Francisco Pozo, Bartolomé Sastre-Palou, Diana Nonković, Mirjam J Knol, Irina Kislaya, Liem Binh Luong Nguyen, Nathalie Bossuyt, Thomas Demuyser, Aušra Džiugytė, Iván Martínez-Baz, Corneliu Popescu, Róisín Duffy, Monika Kuliešė, Lenka Součková, Stella Michelaki, Marc Simon, Janine Reiche, María Teresa Otero-Barrós, Zvjezdana Lovrić Makarić, Patricia Cjl Bruijning-Verhagen, Verónica Gomez, Zineb Lesieur, Cyril Barbezange, Els Van Nedervelde, Maria-Louise Borg, Jesús Castilla, Mihaela Lazar, Joan O'Donnell, Indrė Jonikaitė, Regina Demlová,
Eurosurveillance, 2023, vol. 28
Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands Rutger M. Schepp, Joanna Kaczorowska, Pieter G.M. van Gageldonk, Elsbeth D.M. Rouers, Elisabeth A.M. Sanders, Patricia C.J. Bruijning-Verhagen, Guy A.M. Berbers
Vaccines, 2023, vol. 11

External positions

Adjunct Professor, McGill Univ, McGill University, Dept Epidemiol Biostat & Occupat Hlth